Latest Medicxi Ventures Management (Jersey) Ltd Stock Portfolio
Medicxi Ventures Management (Jersey) Ltd Performance:
2026 Q1: 33.5%YTD: 33.5%2025: 42.99%
Performance for 2026 Q1 is 33.5%, and YTD is 33.5%, and 2025 is 42.99%.
About Medicxi Ventures Management (Jersey) Ltd and 13F Hedge Fund Stock Holdings
On 2026-04-21, the fund reported it's updated stock portfolio. In the 13F Holdings report, Medicxi Ventures Management (Jersey) Ltd reported an equity portfolio of $981.8 Millions as of 31 Mar, 2026.
The top stock holdings of Medicxi Ventures Management (Jersey) Ltd are CNTA, NAMS, PHAT. The fund has invested 80.8% of it's portfolio in CENTESSA PHARMACEUTICALS PLC and 8.7% of portfolio in NEWAMSTERDAM PHARMA COMPANY.
The fund managers got completely rid off RAPT THERAPEUTICS INC (RAPT) stocks. They significantly reduced their stock positions in NEWAMSTERDAM PHARMA COMPANY (NAMS).
The top stock holdings of Medicxi Ventures Management (Jersey) Ltd are CNTA, NAMS, PHAT. The fund has invested 80.8% of it's portfolio in CENTESSA PHARMACEUTICALS PLC and 8.7% of portfolio in NEWAMSTERDAM PHARMA COMPANY.
The fund managers got completely rid off RAPT THERAPEUTICS INC (RAPT) stocks. They significantly reduced their stock positions in NEWAMSTERDAM PHARMA COMPANY (NAMS).
Medicxi Ventures Management (Jersey) Ltd Annual Return Estimates Vs S&P 500
Our best estimate is that Medicxi Ventures Management (Jersey) Ltd made a return of 33.5% in the last quarter. In trailing 12 months, it's portfolio return was 130.73%.
- Performance
- S&P 500
New Buys
Additions
Reductions
| Ticker | % Reduced |
|---|---|
| newamsterdam pharma company | -6.81 |
Medicxi Ventures Management (Jersey) Ltd reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| rapt therapeutics inc | -94,632,800 |
Medicxi Ventures Management (Jersey) Ltd got rid off the above stocks
Sector Distribution
Medicxi Ventures Management (Jersey) Ltd has about 91.3% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 91.3 |
| Others | 8.7 |
Market Cap. Distribution
Medicxi Ventures Management (Jersey) Ltd has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- MID-CAP
- SMALL-CAP
- UNALLOCATED
| Category | % |
|---|---|
| MID-CAP | 80.8 |
| SMALL-CAP | 10.5 |
| UNALLOCATED | 8.7 |
Stocks belong to which Index?
About 10.5% of the stocks held by Medicxi Ventures Management (Jersey) Ltd either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 89.5 |
| RUSSELL 2000 | 10.5 |
Medicxi Ventures Management (Jersey) Ltd Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Medicxi Ventures Management (Jersey) Ltd
Medicxi Ventures Management (Jersey) Ltd has 4 stocks in it's portfolio. PHAT proved to be the most loss making stock for the portfolio. CNTA was the most profitable stock for Medicxi Ventures Management (Jersey) Ltd last quarter.
Last Reported on: 21 Apr, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AURA | aura biosciences inc | 2.07 | 3,039,890 | 20,336,900 | unchanged | 0.00 | ||
| CNTA | centessa pharmaceuticals plc | 80.76 | 19,963,200 | 792,937,000 | unchanged | 0.00 | ||
| NAMS | newamsterdam pharma company | 8.72 | 2,674,180 | 85,600,600 | reduced | -6.81 | ||
| PHAT | phathom pharmaceuticals inc | 8.45 | 7,464,570 | 82,931,400 | unchanged | 0.00 | ||
| RAPT | rapt therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||